Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release

Pakistan Journal of Pharmaceutical Sciences

Volumn 29, Issue 3, 2016, Pages 779-787

  Mehsud, Saif Ullah ^a,b   Khan, Gul Majid ^a,c   Hussain, Abid ^d   Akram, Muhammad ^d   Akhlaq, Muhammad ^a   Khan, Kamran Ahmad ^a   Shakoor, Abdul ^e  

^a GOMAL UNIVERSITY   (Pakistan)

^b HAZARA UNIVERSITY   (Pakistan)

^c QUAID I AZAM UNIVERSITY   (Pakistan)

^d University of Poonch Rawalakot   (Pakistan)

^e Comsat University ^*  (Pakistan)

Author keywords

CMC; Ethocel; Glipizide; Higuachi equation; Hixon Crowel's equation; HPMC; Korsmeyer and Peppas; Starch; Zero order equation

Indexed keywords

ETHYL CELLULOSE; EXCIPIENT; GLIPIZIDE; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; POLYMER; STARCH; SULFONYLUREA; ANTIDIABETIC AGENT; CARBOXYMETHYLCELLULOSE; CELLULOSE; DELAYED RELEASE FORMULATION; POWDER; TABLET;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INCOMPATIBILITY; DRUG SOLUBILITY; DRUG STRUCTURE; HYPOGLYCEMIA; KINETICS; MATRIX TABLET; NON INSULIN DEPENDENT DIABETES MELLITUS; STOMACH DISEASE; TABLET COMPRESSION; TABLET HARDNESS; TABLET THICKNESS; ANALOGS AND DERIVATIVES; CHEMICAL MODEL; CHEMICAL PHENOMENA; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; MEDICINAL CHEMISTRY; PHARMACEUTICS; POWDER; PROCEDURES; SOLUBILITY; TABLET;

CALORIMETRY, DIFFERENTIAL SCANNING; CARBOXYMETHYLCELLULOSE SODIUM; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; GLIPIZIDE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPOGLYCEMIC AGENTS; HYPROMELLOSE DERIVATIVES; KINETICS; MODELS, CHEMICAL; POWDERS; SOLUBILITY; STARCH; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84979709365     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Arunachalam S and Gunasekaran S (2002). Diabetic research in India and China today: From literature-based mapping to health-care policy. Curr. Sci., 82: 1086-1097.
2. Baker G and Weng L (1992). Apparent first order behavior under second order kinetic condition; a general concept illustrated by the reversible binding of hydrogen per oxide to cytochrome coxidase. J. Theor. Biol., 158: 2211-229.
3. Berelowitz M, Fischette C, Cefalu W, Schade D, Sutfin T and Kourides I (1994). Comparative efficacy of once daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM. Diabetes Care, 17: 1460-1464.
4. Blonde I, Guthrie R, Tive L and Fischette C (1996). The Glipizide GITS efficacy and safety trial study group. Glipizide GITS is effective and safe in a wide range of NIDDM patients: Results of a double blind, placebo controlled efficacy and safety trial. Diabetes, 45: 285.
5. Brabander D, Veraet C and Remon J (2003). Development and evaluation of sustained release mini matrices prepared via hot melt extrusion. J. Control Release, 89: 235-247.
6. Brogden R, Heel R, Pakes G, Speight T and Avery G (1979). Glipizide: A review of its pharmacological properties and therapeutic use. Drugs, 18: 329-353.
7. Chowdary K and Rao Y (2003). Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: A technical note. AAPS. Pharm. Sci. Tech., 4: 87-92.
8. Davis S and Granner D (1996). Insulin, oral hypogly-cemic agents and the pharmacotherapy of the endocrine pancreas. Pharmacol. Basis. Therap., 9: 1487-1517.
9. Dash V, Mishra S, Singh M, Goyal A and Rath G (2010). Release kinetic studies of aspirin microcapsules from ethyl cellulose, cellulose acetate phthalate and their mixtures by emulsion solvent evaporation method. Sci. Pharm., 78: 93-101.
10. Deepak Y, Sachin S and Neeraj K (2011). Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: Formulation design and in vitro evaluation. Intern. J. Pharmaceut., 419: 121-130.
11. Dhawan S, Singh B, Garg S, Hota D, Dash R and Singla K and Sinha V (2006). Bioavailability of immediate and extended release formulations of glipizide in healthy male volunteers. Clin. Pharmacokinet., 45: 317-324.
12. Dixon J (1998). The international conference on harmonization good clinical practice guidelines. Qual. Assur., 6: 65-74.
13. Gerich J (1989). Oral hypoglycemic agents. N. Engl. J. Med., 321: 1231-1245.
14. Gohal M, Patel T and Bariyah H (2003). Studies in preparation and evaluation of pH-independent sustained-release matrix tablets of verapamil HCL using directly compressible eudragits. Pharm. Dev. Technol., 8: 323-333.
15. Ford J, Rubinstein M, McCaul F, Hogan J and Edgar P (1987). Importance of drug type, tablet shape and added diluents on release of drug kinetics from HPMC tablets. Int. J. Pharm., 40: 223-234.
16. Hamdy A, Ossama Y and Hesham S (2007). Formulation of controlled release baclofen matrix tablets: Influence of some hydrophilic polymers on the release rate and in vitro evaluation. AAPS Pharm. Sci. Tech., 8: 100.
17. Hsieh D, Rhine W and Langer R (1983). Zero order controlled release polymer matrices for micro-and macromolecules. J. Pharm. Sci., 72: 17-22.
18. Khan G and Median V (2007). Drug release kinetic from tablet matrices based upon ethyl cellulose ether-derivatives: A comparison between different formulations. Drug Dev. Ind. Pharm., 33: 627-639.
19. Khan G and Zhu J (1998). Ibuprofen release kinetics from controlled release tablets granulated with aqueous polymeric dispersion of ethyl cellulose. II: Influence of several parameters and coexcipients. J. Control Release, 56: 127-134.
20. Khan K and Rhodes C (1975). Water soluble properties of tablet disintegrants. J. Pharm. Sci., 64: 447-451.
21. Kuksal A, Tiwary AK, Jain NK and Jain S (2006). Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS. Pharm. Sci. Tech., 7(1): 1-9.
22. Luana P, Valeria A, Fausta A, Maurizio R, Stefano G, Marinella C and Carlo R (2004). Development of mucoadhesive patches for buccal administration of ibuprofen. J. Control Release, 99: 73-82.
23. Malaterre V, Ogorka J and Loggia N (2009). Evaluation of the tablet core factors influencing the release kinetics and the load ability of push pull osmotic system. Drug Dev. Ind. Pharm., 35: 433-439.
24. Marchetti P and Navalesi R (1989). Pharmacokinetic-pharmacodynamic relationships of oral hypoglycemic agents. Clin. Pharmacokin, 16: 100-128.
25. Mehrgan H and Mortazavi S (2005). The release behavior and kinetics evaluation of diltiazem HCl from various hydrophilic and plastic based matrices. Iran. J. Pharm. Res., 4: 137-146.
26. Nolte M and Karam J (2003). Pancreatic hormones and antidiabetic drugs. Basis and Clin. Pharmacol., 8: 683-705.
27. Sanchez L, Faucci M, Fernandez A, Alvarez F, Rabasco A and Mura P (2002"a"). Development of sustained release matrix tablets of didanosine contain is methacyclic and ethyl cellulose polymers. Int. J. Pharm., 234: 213-221.
28. Saravanan M, Natraj K and Ganesh K (2003). Hydroxypropyl methylcellulose based cephalexin extended release tablets: Influence of tablet formulation, hardness and storage on in vivo release kinetics. Chem. Pharm. Bull, 51: 978-983.
29. Siepmann J and Peppas N (2011). Higushi equation: derivation, applications, use and misuse. Int. J. Pharm., 418: 6-12.
30. Soni T and Chotai N (2010). Assessment of dissolution profile of marketed acelofenac formulation. J. Young. Pharm., 2: 21-26.
31. Yogeshwar GB and Vandana BP (2009). Smedds of glyburide: Formulation, In vitro evaluation and stability studies. AAPS. Pharm. Sci. Tech., 10: 482-487.